Probably a silly question, but re COGS, wouldn't this include expenses relating to the numerous trials being completed by the company currently?
It is also my understanding that customers are providing funding for the trials, therefore revenue should equal COGS for the trials. Therefore if these trial payments are making up a large portion of revenue (as I would suspect given the stage the company is at) and therefore COGS would be a high percentage.
Just a thought?
DYOR
Probably a silly question, but re COGS, wouldn't this include...
Add AJX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.46M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42000 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 134311 | 1 |
View Market Depth
| Last trade - 16.12pm 08/10/2024 (20 minute delay) ? |
| AJX (ASX) Chart |
Day chart unavailable